Jeffrey M. Leiden, Executive Chairman of Vertex Pharmaceuticals Inc. ($VRTX), sold shares on the open market 17 times over the last year, totaling $60.9 million. His most recent sale occurred on December 3, 2025. These sales rank 260th among 11,678 individual insiders by total value sold, surpassing the average of $8.6 million across about 6 transactions per insider. Leiden made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | F | Common Stock | 3547 | $485.11 | 35,237.0000 | 258,000,000 | 9.15% | 0.00% |
| Feb. 17, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | A | Common Stock | 8269 | $0.00 | 41,748.0000 | 258,000,000 | 24.70% | 0.00% |
| Feb. 18, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | F | Common Stock | 2964 | $483.75 | 38,784.0000 | 258,000,000 | 7.10% | 0.00% |
| Jan. 22, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | A | Common Stock | 9012 | $0.00 | 33,479.0000 | 258,000,000 | 36.83% | 0.00% |
| Dec. 3, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 2469 | $443.21 | 79,989.0000 | 258,600,000 | 2.99% | 0.00% |
| Dec. 3, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 2070 | $455.22 | 24,466.0000 | 258,600,000 | 7.80% | 0.00% |
| Dec. 3, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 10360 | $453.34 | 26,536.0000 | 258,600,000 | 28.08% | 0.00% |
| Dec. 3, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 15681 | $452.20 | 36,896.0000 | 258,600,000 | 29.82% | 0.01% |
| Dec. 3, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | M | Common Stock | 63781 | $86.52 | 88,247.0000 | 258,600,000 | 260.69% | 0.02% |
| Dec. 3, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 4469 | $440.40 | 83,778.0000 | 258,600,000 | 5.06% | 0.00% |
| Dec. 3, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 1320 | $441.26 | 82,458.0000 | 258,600,000 | 1.58% | 0.00% |
| Dec. 3, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 5809 | $451.20 | 52,577.0000 | 258,600,000 | 9.95% | 0.00% |
| Dec. 3, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 5880 | $449.84 | 58,386.0000 | 258,600,000 | 9.15% | 0.00% |
| Dec. 3, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 2320 | $448.78 | 64,266.0000 | 258,600,000 | 3.48% | 0.00% |
| Dec. 3, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 1152 | $447.05 | 66,586.0000 | 258,600,000 | 1.70% | 0.00% |
| Dec. 3, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 7899 | $445.56 | 67,738.0000 | 258,600,000 | 10.44% | 0.00% |
| Dec. 3, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 4352 | $444.36 | 75,637.0000 | 258,600,000 | 5.44% | 0.00% |
| Dec. 4, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | M | Common Stock | 1 | $91.05 | 24,467.0000 | 258,600,000 | 0.00% | 0.00% |
| Dec. 3, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | M | Stock Option (Right to Buy) | 63781 | $0.00 | 0.0000 | 258,600,000 | 100.00% | 0.02% |
| Dec. 4, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | M | Stock Option (Right to Buy) | 1 | $0.00 | 0.0000 | 258,600,000 | 100.00% | 0.00% |
| Nov. 14, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 40 | $442.00 | 24,466.0000 | 258,600,000 | 0.16% | 0.00% |
| Nov. 13, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | M | Common Stock | 19688 | $91.05 | 44,154.0000 | 258,600,000 | 80.47% | 0.01% |
| Nov. 13, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 18528 | $440.22 | 25,626.0000 | 258,600,000 | 41.96% | 0.01% |
| Nov. 13, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 1160 | $441.05 | 24,466.0000 | 258,600,000 | 4.53% | 0.00% |
| Nov. 14, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | M | Common Stock | 13835 | $91.05 | 38,301.0000 | 258,600,000 | 56.55% | 0.01% |
| Nov. 14, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | M | Common Stock | 39769 | $86.52 | 78,070.0000 | 258,600,000 | 103.83% | 0.02% |
| Nov. 14, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 32234 | $440.30 | 45,836.0000 | 258,600,000 | 41.29% | 0.01% |
| Nov. 14, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 21330 | $441.35 | 24,506.0000 | 258,600,000 | 46.54% | 0.01% |
| Nov. 13, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | M | Stock Option (Right to Buy) | 19688 | $0.00 | 13,836.0000 | 258,600,000 | 58.73% | 0.01% |
| Nov. 14, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | M | Stock Option (Right to Buy) | 13835 | $0.00 | 1.0000 | 258,600,000 | 99.99% | 0.01% |
| Nov. 14, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | M | Stock Option (Right to Buy) | 39769 | $0.00 | 63,781.0000 | 258,600,000 | 38.41% | 0.02% |
| Feb. 14, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | F | Common Stock | 6066 | $463.46 | 24,466.0000 | 257,899,999 | 19.87% | 0.00% |
| Feb. 12, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | A | Common Stock | 7209 | $0.00 | 33,057.0000 | 257,899,999 | 27.89% | 0.00% |
| Feb. 13, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | F | Common Stock | 2525 | $450.83 | 30,532.0000 | 257,899,999 | 7.64% | 0.00% |
| Feb. 4, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | A | Common Stock | 15414 | $0.00 | 25,848.0000 | 257,899,999 | 147.73% | 0.01% |
| Aug. 30, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 3784 | $499.00 | 10,434.0000 | 260,500,000 | 26.61% | 0.00% |
| Feb. 20, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | F | Common Stock | 4118 | $420.58 | 14,218.0000 | 260,500,000 | 22.46% | 0.00% |
| Feb. 14, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 4356 | $419.04 | 22,991.0000 | 260,500,000 | 15.93% | 0.00% |
| Feb. 15, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 4655 | $419.16 | 18,336.0000 | 260,500,000 | 20.25% | 0.00% |
| Feb. 12, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 647 | $420.39 | 28,084.0000 | 260,500,000 | 2.25% | 0.00% |
| Feb. 12, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 2009 | $419.22 | 28,731.0000 | 260,500,000 | 6.54% | 0.00% |
| Feb. 13, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 737 | $419.13 | 27,347.0000 | 260,500,000 | 2.62% | 0.00% |
| Feb. 8, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | F | Common Stock | 2698 | $421.73 | 38,788.0000 | 260,500,000 | 6.50% | 0.00% |
| Feb. 9, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | F | Common Stock | 8048 | $422.74 | 30,740.0000 | 260,500,000 | 20.75% | 0.00% |
| Feb. 7, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | A | Common Stock | 7707 | $0.00 | 41,486.0000 | 260,500,000 | 22.82% | 0.00% |
| Feb. 6, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | A | Common Stock | 10464 | $0.00 | 13,327.0000 | 260,500,000 | 365.49% | 0.00% |
| Feb. 6, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | A | Common Stock | 20452 | $0.00 | 33,779.0000 | 260,500,000 | 153.46% | 0.01% |
| Jan. 8, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | LEIDEN JEFFREY M | Executive Chairman | S | Common Stock | 6648 | $419.07 | 2,863.0000 | 260,500,000 | 69.90% | 0.00% |